A
24.80
2.54 (11.41%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Alto Neuroscience, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
0.8
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.75 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 7.48% |
| 机构持股比例 | 77.52% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Alpha Wave Global, Lp | 31 Dec 2025 | 3,707,757 |
| Vestal Point Capital, Lp | 31 Dec 2025 | 2,485,000 |
| Commodore Capital Lp | 31 Dec 2025 | 1,823,196 |
| Perceptive Advisors Llc | 31 Dec 2025 | 1,784,393 |
| Armistice Capital, Llc | 31 Dec 2025 | 1,536,000 |
| Vivo Capital, Llc | 31 Dec 2025 | 1,035,551 |
| 72 Investment Holdings, Llc | 31 Dec 2025 | 667,778 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (Chardan Capital, 20.97%) | 购买 |
| 中 | 29.00 (16.94%) | |
| 低 | 28.00 (BTIG, 12.90%) | 购买 |
| 平均值 | 29.00 (16.94%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 17.90 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 17 Feb 2026 | 28.00 (12.90%) | 购买 | 19.26 |
| Chardan Capital | 05 Jan 2026 | 30.00 (20.97%) | 购买 | 16.53 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合